Prosecution Insights
Last updated: August 18, 2026

Examiner: ROBINSON, KYLE G

Tech Center 3700 • Art Units: 2863 3626 3681 3682 3685 3796

This examiner grants 12% of resolved cases

Performance Statistics

11.8%
Allow Rate
-58.2% vs TC avg
249
Total Applications
+16.7%
Interview Lift
1423
Avg Prosecution Days
Based on 211 resolved cases, 2023–2026

Rejection Statute Breakdown

34.9%
§101 Eligibility
7.1%
§102 Novelty
31.4%
§103 Obviousness
25.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19083834 PRIME DIFFERENTIATION IN MEDICATION DELIVERY SYSTEM Non-Final OA Medtronic MiniMed, Inc.
18882633 METHOD, APPARATUS, DEVICE AND STORAGE MEDIUM FOR INFORMATION INTERACTION Non-Final OA Beijing Zitiao Network Technology Co., Ltd.
19003413 MEDICAL IMAGE ANALYZING APPARATUS, MEDICAL IMAGE ANALYZING METHOD, AND MEDICAL INFORMATION PROCESSING APPARATUS Final Rejection CANON KABUSHIKI KAISHA
18909810 MEDICAL INFORMATION PROCESSING APPARATUS, MEDICAL INFORMATION PROCESSING SYSTEM AND MEDICAL INFORMATION PROCESSING METHOD Non-Final OA Canon Kabushiki Kaisha
18049707 MEDICAL IMAGE IMAGING SYSTEM, OPERATION AUTHORITY CONTROL METHOD, AND COMPUTER-READABLE NONVOLATILE STORAGE MEDIUM STORING OPERATION AUTHORITY CONTROL PROGRAM Final Rejection CANON MEDICAL SYSTEMS CORPORATION
19144950 METHODS FOR EARLY-AGE EYE-TRACKING BIOMARKER FOR AUTISM SPECTRUM DISORDER Non-Final OA The Regents of the University of California
19052957 CLINICAL TRIAL PLANNING DEVICE AND CLINICAL TRIAL PLANNING METHOD Final Rejection Hitachi, Ltd.
18816106 HEALTHCARE IMPROVEMENT BASED ON COMPOSITE HEALTHCARE SCORES Non-Final OA Hill-Rom Services, Inc.
19105243 CONVOLUTIONAL NEURAL NETWORK CLASSIFICATION OF PRETREATMENT BIOPSIES Non-Final OA Washington University
18253760 Method for Supporting a Patient's Health Control and Respective System Non-Final OA BIOTRONIK SE & Co. KG
19003243 EARLY DETECTION TOOLS FOR MENTAL HEALTH Non-Final OA Pandora Bio, Inc.
18359056 Systems and Methods for Transferring Multi-Frame Image Data Final Rejection IDEXX Laboratories, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month